It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Automated grading of colon biopsy images across all magnifications is challenging because of tailored segmentation and dependent features on each magnification. This work presents a novel approach of robust magnification-independent colon cancer grading framework to distinguish colon biopsy images into four classes: normal, well, moderate, and poor. The contribution of this research is to develop a magnification invariant hybrid feature set comprising cartoon feature, Gabor wavelet, wavelet moments, HSV histogram, color auto-correlogram, color moments, and morphological features that can be used to characterize different grades. Besides, the classifier is modeled as a multiclass structure with six binary class Bayesian optimized random forest (BO-RF) classifiers. This study uses four datasets (two collected from Indian hospitals—Ishita Pathology Center (IPC) of 4X, 10X, and 40X and Aster Medcity (AMC) of 10X, 20X, and 40X—two benchmark datasets—gland segmentation (GlaS) of 20X and IMEDIATREAT of 10X) comprising multiple microscope magnifications. Experimental results demonstrate that the proposed method outperforms the other methods used for colon cancer grading in terms of accuracy (97.25%-IPC, 94.40%-AMC, 97.58%-GlaS, 99.16%-Imediatreat), sensitivity (0.9725-IPC, 0.9440-AMC, 0.9807-GlaS, 0.9923-Imediatreat), specificity (0.9908-IPC, 0.9813-AMC, 0.9907-GlaS, 0.9971-Imediatreat) and F-score (0.9725-IPC, 0.9441-AMC, 0.9780-GlaS, 0.9923-Imediatreat). The generalizability of the model to any magnified input image is validated by training in one dataset and testing in another dataset, highlighting strong concordance in multiclass classification and evidencing its effective use in the first level of automatic biopsy grading and second opinion.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer